Physician profile
David Wong
NPI 1023202280
$3,886.00
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,032 · 2020: $477 · 2021: $1,446 · 2022: $931.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $801.50 | 2019-2022 | |
| Boston Scientific Corporation | $791.98 | 2019-2022 | |
| Abbott Laboratories | $616.30 | 2019-2022 | |
| Nutech Spine, INC. | $500.00 | 2022 | |
| Scilex Pharmaceuticals INC. | $197.42 | 2019-2022 | |
| Nevro Corp. | $112.54 | 2019 | |
| Vertos Medical, INC. | $108.59 | 2020-2022 | |
| Pfizer INC. | $107.18 | 2019-2020 | |
| Si-Bone, INC. | $96.70 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $78.20 | 2019-2021 | |
| Medtronic USA, INC. | $65.08 | 2020 | |
| Collegium Pharmaceutical, INC. | $45.40 | 2019-2021 | |
| Amgen INC. | $44.55 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $33.63 | 2021 | |
| Orexo US, INC. | $31.35 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $29.22 | 2022 | |
| Arbor Pharmaceuticals, INC. | $27.21 | 2019-2020 | |
| Redhill Biopharma INC. | $22.16 | 2021 | |
| Nalu Medical, INC. | $21.95 | 2021 | |
| Zimmer Biomet Holdings, INC. | $20.29 | 2022 | |
| Spinal Simplicity, LLC | $19.32 | 2022 | |
| Clovis Oncology, INC. | $18.57 | 2020 | |
| Fidia Pharma USA INC. | $18.53 | 2022 | |
| Daiichi Sankyo INC. | $18.01 | 2019 | |
| Orthogenrx INC. | $17.14 | 2019 | |
| Ibsa Pharma INC. | $16.73 | 2021 | |
| Allergan, INC. | $13.68 | 2021 | |
| Painteq LLC | $12.77 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.